Clinical Trials Browser

Glioblastoma × Peptides × Clear all

NCT03223103 2025-09-10

Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma

Phase 1 Active not recruiting

Brain Neoplasms, Glioblastoma, Neoplasms